Dr. Stephanie Venn-Watson, DVM, MPH is the Co-Founder and CEO of Seraphina Therapeutics, a pioneering health and wellness company dedicated to discovering and developing essential fatty acids that support longevity and overall well-being. A veterinary epidemiologist and the world's foremost expert on C15:0, the first essential fatty acid discovered in over 90 years, Stephanie has revolutionized the way we think about nutrition and aging.

Her career spans impactful roles, including serving as an epidemiologist for the World Health Organization and U.S. Navy. With over 60 patents and 80 peer-reviewed publications, her innovative approach to nutrient-based therapeutics has been spotlighted by NPR's Science Friday, CBS, BBC, and National Geographic.

Stephanie's groundbreaking contributions have earned her prestigious accolades, including the Department of Health and Human Services Secretary's Award for Innovations in Disease Prevention and Health Promotion and Boehringer Ingelheim's Innovation Award. Under her leadership, Seraphina Therapeutics has been recognized as a Fast Company World Changing Idea and won Nutritional Outlook Magazine's Best of the Industry award for its pure C15:0 ingredient.

She holds a B.S. in Animal Physiology and Neuroscience from UC San Diego, a D.V.M. from Tufts University, and an M.P.H. from Emory University. She was also a National Research Council Associate with the Armed Forces Medical Intelligence Center and is an Albert Schweitzer Fellow for Life.